Patterns and Management of Selected Adverse Events of Adult Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia (CML) From the ENACT (Expanding Nilotinib Access in Clinical Trials) Study.
Conference Paper
Full Text
Duke Authors
Cited Authors
- le Coutre, PD; Ceglarek, B; Turkina, A; Kim, D-W; Alimena, G; Al-Ali, HK; Shen, Z; Jootar, S; Smith, G; De Souza, CA; Rizzieri, DA; Szczudlo, T; Berton, M; Wang, J; Dial, E; Nicolini, FE
Published Date
- November 20, 2009
Published In
Volume / Issue
- 114 / 22
Start / End Page
- 457 - 458
Published By
Pages
- 2
International Standard Serial Number (ISSN)
- 0006-4971
Conference Name
- 51st Annual Meeting of the American-Society-of-Hematology
Conference Location
- New Orleans, LA
Conference Start Date
- December 5, 2009
Conference End Date
- December 8, 2009